Achieve Life Sciences, Inc. (ACHV): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2012-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

53.23M
As of 2025-12-31
102.72M
As of 2026-06-30
+43.8%
3-year compound annual growth
2010-12-31: 9.69M2011-12-31: 9.75M2012-12-31: 14.66M2013-12-31: 14.71M2014-12-31: 22.62M2015-12-31: 29.81M2016-12-31: 21.2K2017-12-31: 1.19M2018-12-31: 6.72M2019-12-31: 1.47M2020-12-31: 6.11M2021-12-31: 9.45M2022-12-31: 17.90M2023-12-31: 21.17M2024-12-31: 34.69M2025-12-31: 53.23M53.23M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3153.23M+53.5%2026-03-24, Balance as of period end
2024-12-3134.69M+63.9%2026-03-24, Balance as of period end
2023-12-3121.17M+18.3%2025-03-11, Balance as of period end
2022-12-3117.90M+89.3%2024-03-28, Balance as of period end
2021-12-319.45Mn/c2023-03-16, Balance as of period end
2020-12-316.11Mn/c2022-03-10, Balance as of period end
2019-12-311.47M-78.1%2021-03-11, Balance as of period end
2018-12-316.72M+462.5%2020-03-13, Balance as of period end
2017-12-311.19Mn/m2019-03-14, Balance as of period end
2016-12-3121.2K-99.9%2018-03-01, Balance as of period end
2015-12-3129.81M+31.8%2017-02-23, Balance as of period end
2014-12-3122.62Mn/c2016-03-09, Balance as of period end
2013-12-3114.71M+0.3%2015-03-26, Balance as of period end
2012-12-3114.66Mn/c2014-03-11, Balance as of period end
2011-12-319.75M+0.6%2013-03-07, Balance as of period end
2010-12-319.69Mn/a2012-03-08, Balance as of period end